Provided by Tiger Trade Technology Pte. Ltd.

JUNSHI BIO

16.980
-0.300-1.74%
Volume:1.29M
Turnover:21.83M
Market Cap:17.44B
PE:-19.52
High:17.260
Open:17.240
Low:16.760
Close:17.280
52wk High:33.880
52wk Low:15.250
Shares:1.03B
HK Float Shares:260.00M
Volume Ratio:0.92
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.870
ROE:-9.32%
ROA:-2.23%
PB:2.51
PE(LYR):-19.52
PS:4.93

Loading ...

Junshi Biosciences Surges Over 3% on Plans to Launch Pivotal Phase III Trials for Two Bispecific Antibody Drugs This Year

Stock News
·
Sep 14

AH Share Premium Rankings: September 10 Market Close Update

Stock News
·
Sep 10

AH Share Premium Rankings as of September 9 Trading Close

Stock News
·
Sep 09

UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts

Stock News
·
Sep 07

Junshi Biosciences Schedules 2026 Interim Results Conference Call

Deep News
·
Sep 04

Junshi Bio Schedules 2026 Interim Results Briefing for 14 September

Bulletin Express
·
Sep 04

AH Premium Rankings Update: September 3 Market Close

Stock News
·
Sep 03

AH Premium Rankings for September 2nd Market Close

Stock News
·
Sep 02

AH Share Premium Rankings for September 1st

Stock News
·
Sep 01

Shanghai Junshi Biosciences Says Shanghai Tanying Investment Plans Reduction Stake

MT Newswires Live
·
Aug 31

AH Share Premium Report: August 31 Market Close

Stock News
·
Aug 31

Junshi Bio: Shanghai Tanying Plans to Cut Up to 2% Stake by December 2026

Bulletin Express
·
Aug 31

AH Premium Rankings for August 27: A Market Overview

Stock News
·
Aug 27

Shanghai Junshi Biosciences Estimates 35 Million Yuan in Related-Party Transactions

MT Newswires Live
·
Aug 27

Press Release: Junshi Biosciences Announces 2026 Interim Financial Results and Provides Corporate Updates

Dow Jones
·
Aug 27

Junshi Biosciences Reports First-Half Net Profit of RMB21.66 Million, Reversing Year-Earlier Loss

Stock News
·
Aug 27

Junshi Bio Terminates 2026 A-Share Employee Stock Ownership Scheme

Bulletin Express
·
Aug 26

Shanghai Junshi Biosciences Return to Profit in H1

MT Newswires Live
·
Aug 26

Junshi Bio Turns Profitable as H1 2026 Revenue Leaps 45% to RMB1.70 Billion on Strong TUOYI® Momentum

Bulletin Express
·
Aug 26

Junshi Biosciences Swings to Profit in First-Half Results

Stock News
·
Aug 26